MedDataX Logo

Cultural Adaptation of a Self-help App for Grieving Syrian Refugees in Switzerland

NCT06246708 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-08-09

No results posted yet for this study

Summary

The goal of this pilot RCT is to investigate the acceptability and feasibility of an unguided culturally adapted self-help app for grieving Syrian refugees in Switzerland. Furthermore, the study will examine whether using the app has an effect on secondary outcomes (e.g., grief symptoms).The main questions it aims to answer are:

* Is the self-help app culturally acceptable and feasible in this target group and what do we need to adapt?
* Does the use of the self-help app reduce grief symptoms? (amongst other secondary outcomes)

Participants will be asked to:

* Complete a baseline assessment
* then use the self-help app for 5 weeks
* Complete a second assessment and participate in a short semi-structured interview regarding acceptability and feasibility.

Researchers will compare an intervention group to a wait-list control group to see if the use of the self-help app has an effect on secondary outcomes.

Conditions

  • Bereavement

Interventions

OTHER

Self-help app with information for grieving Syrian Refugees

This study explores a self-help app for grieving Syrian refugees in Switzerland, featuring five chapters on grief, resources, space, negative thoughts, and future self-help. The Arabic app includes psychoeducational content, audio exercises, and videos. Users personalize it, save favorites, and set reminders. Tailored for Arabic-speaking refugees, it's accessible on iOS and Android, without invasive components. Participants complete one weekly chapter over five weeks. Data input is stored without manipulation. Accessible data includes completed chapters, subchapters, and feedback. The app promotes self-help, respecting cultural nuances for user engagement.

OTHER

Wait-list

Participants in the wait-list control group, receive access to the same intervention described above after a waiting period of 5 weeks.

Sponsors & Collaborators

  • Swiss Transfusion SRC

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Myriam Thoma, PD Dr. · University of Zurich

  • Anaïs Aeschlimann, MSc · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-29
Primary Completion
2024-06-17
Completion
2024-06-17

Countries

  • Switzerland

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06246708 on ClinicalTrials.gov